| Getty Images Key Takeaways Amgen announced positive results from a phase I trial of its new obesity drug, AMG 133. After its earnings announcement and the trial results, Amgen stock rose more than 5...
| Getty Images Key Takeaways Amgen announced positive results from a phase I trial of its new obesity drug, AMG 133. After its earnings announcement and the trial results, Amgen stock rose more than 5...